Converting Enzyme-Inhibition in Diabetic Nephropathy

Contributions to Nephrology - Diabetes and the Kidney ◽

10.1159/000417388 ◽

2015 ◽

pp. 160-162 ◽

Cited By ~ 2

Author(s):

Elisabeth R. Mathiesen ◽

Hans-Henrik Parving ◽

Eva Hommel

Keyword(s):

Diabetic Nephropathy ◽

Enzyme Inhibition ◽

Converting Enzyme ◽

Converting Enzyme Inhibition

Download Full-text

Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy

Journal of the American Society of Nephrology ◽

10.1681/asn.2009070737 ◽

2009 ◽

Vol 20 (12) ◽

pp. 2641-2650 ◽

Cited By ~ 233

Author(s):

Uzma F. Mehdi ◽

Beverley Adams-Huet ◽

Philip Raskin ◽

Gloria L. Vega ◽

Robert D. Toto

Keyword(s):

Diabetic Nephropathy ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibition ◽

Angiotensin Converting Enzyme Inhibition ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibition ◽

Angiotensin Receptor Blockade

Download Full-text

Angiotensin-Converting Enzyme Inhibition in Type I Diabetic Nephropathy

Contributions to Nephrology - Progression of Chronic Renal Diseases ◽

10.1159/000425095 ◽

2015 ◽

pp. 206-213 ◽

Cited By ~ 5

Author(s):

Edmund J. Lewis

Keyword(s):

Diabetic Nephropathy ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibition ◽

Angiotensin Converting Enzyme Inhibition ◽

Type I ◽

Converting Enzyme ◽

Converting Enzyme Inhibition

Download Full-text

The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

New England Journal of Medicine ◽

10.1056/nejm199311113292004 ◽

1993 ◽

Vol 329 (20) ◽

pp. 1456-1462 ◽

Cited By ~ 3493

Author(s):

Edmund J. Lewis ◽

Lawrence G. Hunsicker ◽

Raymond P. Bain ◽

Richard D Rohde

Keyword(s):

Diabetic Nephropathy ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibition ◽

Angiotensin Converting Enzyme Inhibition ◽

Converting Enzyme ◽

Converting Enzyme Inhibition

Download Full-text

ANGIOTENSIN-CONVERTING ENZYME INHIBITION IN DIABETIC NEPHROPATHY IN ADOLESCENTS (LONG-TERM TREATMENT). SISTOLIC BLOOD PRESSURE AS PROGRESSION PROMOTER: PP.17.167

Journal of Hypertension ◽

10.1097/01.hjh.0000379093.78287.38 ◽

2010 ◽

Vol 28 ◽

pp. e299

Author(s):

I Aleksandrova ◽

T Shyryaeva

Keyword(s):

Blood Pressure ◽

Diabetic Nephropathy ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibition ◽

Term Treatment ◽

Angiotensin Converting Enzyme Inhibition ◽

Converting Enzyme ◽

Long Term Treatment ◽

Converting Enzyme Inhibition

Download Full-text

Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy

Yearbook of Medicine ◽

10.1016/s0084-3873(10)79697-8 ◽

2010 ◽

Vol 2010 ◽

pp. 206-208

Author(s):

R. Garrick

Keyword(s):

Diabetic Nephropathy ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibition ◽

Angiotensin Converting Enzyme Inhibition ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibition ◽

Angiotensin Receptor Blockade

Download Full-text

The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

New England Journal of Medicine ◽

10.1056/nejm199403313301314 ◽

1994 ◽

Vol 330 (13) ◽

pp. 937-938 ◽

Cited By ~ 7

Keyword(s):

Diabetic Nephropathy ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibition ◽

Angiotensin Converting Enzyme Inhibition ◽

Converting Enzyme ◽

Converting Enzyme Inhibition

Download Full-text

Faculty Opinions recommendation of Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1448963.926064 ◽

2010 ◽

Author(s):

Mai Ots-Rosenberg

Keyword(s):

Diabetic Nephropathy ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibition ◽

Angiotensin Converting Enzyme Inhibition ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibition ◽

Angiotensin Receptor Blockade

Download Full-text

Faculty of 1000 evaluation for Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.1448963.2221054 ◽

2010 ◽

Author(s):

Luigi Gnudi

Keyword(s):

Diabetic Nephropathy ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibition ◽

Angiotensin Converting Enzyme Inhibition ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibition ◽

Angiotensin Receptor Blockade

Download Full-text

Angiotensin-converting enzyme inhibition in diabetic nephropathy: Ten years' experience

American Journal of Kidney Diseases ◽

10.1016/0272-6386(95)90162-0 ◽

1995 ◽

Vol 26 (1) ◽

pp. 99-107 ◽

Cited By ~ 63

Author(s):

Hans-Henrik Parving ◽

Peter Rossing ◽

Eva Hommel ◽

Ulla M. Smidt

Keyword(s):

Diabetic Nephropathy ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibition ◽

Angiotensin Converting Enzyme Inhibition ◽

Converting Enzyme ◽

Converting Enzyme Inhibition

Download Full-text

Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy: It’s All the RAGE

Journal of the American Society of Nephrology ◽

10.1681/asn.2005060595 ◽

2005 ◽

Vol 16 (8) ◽

pp. 2251-2253 ◽

Cited By ~ 7

Author(s):

Raymond Harris

Keyword(s):

Diabetic Nephropathy ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibition ◽

Angiotensin Converting Enzyme Inhibition ◽

Converting Enzyme ◽

Converting Enzyme Inhibition

Download Full-text